Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Catalyst Pharma to Be Acquired by Angelini Pharma in $4.1 Billion Deal
Italy's Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1 billion
See How Institutions Boost Catalyst Shares